Share on StockTwits

SciClone Pharmaceuticals (NASDAQ:SCLN) is scheduled to issue its quarterly earnings data on Monday, May 12th. SciClone Pharmaceuticals has set its FY14 guidance at $0.41-0.47 EPS.Persons that wish to listen to the company’s earnings conference call can do so using this link.

SciClone Pharmaceuticals (NASDAQ:SCLN) last posted its quarterly earnings results on Wednesday, March 12th. The company reported $0.08 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.15 by $0.07. The company had revenue of $32.70 million for the quarter, compared to the consensus estimate of $38.30 million. During the same quarter in the prior year, the company posted $0.03 earnings per share. The company’s quarterly revenue was down 1.2% on a year-over-year basis. On average, analysts expect SciClone Pharmaceuticals to post $0.34 EPS for the current fiscal year and $0.45 EPS for the next fiscal year.

Shares of SciClone Pharmaceuticals (NASDAQ:SCLN) opened at 4.69 on Friday. SciClone Pharmaceuticals has a 52-week low of $4.24 and a 52-week high of $6.30. The stock’s 50-day moving average is $4. and its 200-day moving average is $4.77. The company has a market cap of $243.7 million and a price-to-earnings ratio of 23.65.

SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) is a specialty pharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.